111 Price to Sales Ratio 2018-2024 | YI

Historical PS ratio values for 111 (YI) over the last 10 years. The current P/S ratio for 111 as of April 22, 2025 is . For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
111 P/S Ratio Historical Data
Date Stock Price TTM Sales per Share Price to Sales Ratio
2025-04-22 8.38 0.03
2024-09-30 7.56 $241.16 0.03
2024-06-30 10.65 $240.89 0.04
2024-03-31 11.60 $242.97 0.05
2023-12-31 15.50 $250.23 0.06
2023-09-30 26.00 $248.64 0.10
2023-06-30 24.60 $245.69 0.10
2023-03-31 26.50 $243.07 0.11
2022-12-31 30.20 $235.30 0.13
2022-09-30 26.80 $235.75 0.11
2022-06-30 20.60 $241.86 0.09
2022-03-31 26.60 $243.92 0.11
2021-12-31 35.00 $235.18 0.15
2021-09-30 61.70 $222.39 0.28
2021-06-30 90.85 $202.02 0.45
2021-03-31 138.00 $173.39 0.80
2020-12-31 69.50 $152.64 0.46
2020-09-30 62.00 $120.68 0.51
2020-06-30 63.50 $97.40 0.65
2020-03-31 66.10 $84.45 0.78
2019-12-31 67.30 $69.33 0.97
2019-09-30 48.70 $61.90 0.79
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.064B $1.973B
111, Inc. operates as a digital and mobile healthcare platform. The Company offers pharmacy distribution, medical consultancy, e-prescription and other services. 111, Inc. is headquartered in Shanghai, China.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $35.134B 48.53
Tempus AI (TEM) United States $6.966B 0.00
Hims & Hers Health (HIMS) United States $6.050B 97.25
Inspire Medical Systems (INSP) United States $4.470B 86.83
IRhythm Technologies (IRTC) United States $3.223B 0.00
Privia Health (PRVA) United States $2.873B 215.27
Schrodinger (SDGR) United States $1.881B 0.00
Clover Health Investments (CLOV) United States $1.839B 0.00
Enovis (ENOV) United States $1.825B 11.29
Omnicell (OMCL) United States $1.418B 30.59
Phreesia (PHR) United States $1.409B 0.00
Azenta (AZTA) United States $1.154B 53.72
10x Genomics (TXG) United States $0.918B 0.00
Butterfly Network (BFLY) United States $0.568B 0.00
Fulgent Genetics (FLGT) United States $0.551B 0.00
Talkspace (TALK) United States $0.450B 267.00
Veradigm (MDRX) United States $0.449B 0.00
Standard BioTools (LAB) United States $0.440B 0.00
TruBridge (TBRG) United States $0.363B 0.00
Claritev (CTEV) United States $0.325B 0.00
Health Catalyst (HCAT) United States $0.270B 0.00
Nyxoah SA (NYXH) Belgium $0.206B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.189B 0.00
Pulmonx (LUNG) United States $0.182B 0.00
American Well (AMWL) United States $0.109B 0.00
EUDA Health Holdings (EUDA) Singapore $0.100B 0.00
Retrieve Medical Holdings (RMHI) United States $0.082B 0.00
MDxHealth SA (MDXH) Belgium $0.076B 0.00
P3 Health Partners (PIII) United States $0.066B 0.00
CareCloud (CCLD) United States $0.060B 2.58
HeartBeam (BEAT) United States $0.055B 0.00
Outset Medical (OM) United States $0.040B 0.00
Zepp Health (ZEPP) China $0.039B 0.00
Zhongchao (ZCMD) China $0.030B 0.00
Bullfrog AI Holdings (BFRG) United States $0.016B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.014B 0.00
MSP Recovery (MSPR) United States $0.014B 0.00
Strata Skin Sciences (SSKN) United States $0.011B 0.00
Streamline Health Solutions (STRM) United States $0.010B 0.00
Healthcare Triangle (HCTI) United States $0.009B 0.00
Precipio (PRPO) United States $0.009B 0.00
Predictive Oncology (POAI) United States $0.008B 0.00
Movano (MOVE) United States $0.007B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Syra Health (SYRA) United States $0.001B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00